Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis

References

• Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244–60.e16. doi:10.1053/j.gastro.2014.12.035.
   PubMed Web of Science ®Google Scholar
• Chow CJ, Al-Refaie WB, Abraham A, Markin A, Zhong W, Rothenberger DA, Kwaan MR, Habermann EB. Does patient rurality predict quality colon cancer care?: a population-based study. Dis Colon Rectum. 2015;58(4):415–20. doi:10.1097/DCR.0000000000000173.
   PubMed Web of Science ®Google Scholar
• Allen J, Sears CL. Impact of the gut microbiome on the genome and epigenome of colon epithelial cells: contributions to colorectal cancer development. Genome Med. 2019;11(1):11. doi:10.1186/s13073-019-0621-2.
   PubMed Web of Science ®Google Scholar
• Gagnaire A, Nadel B, Raoult D, Neefjes J, Gorvel JP. Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer. Nat Rev Microbiol. 2017;15(2):109–128. doi:10.1038/nrmicro.2016.171.
   PubMed Web of Science ®Google Scholar
• Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, Stege, PB. et al. Mutational signature in colorectal cancer caused by genotoxic pks+. E coli Nat. 2020;580:269–273.
   PubMed Web of Science ®Google Scholar
• Sears CL, Pardoll DM. Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J Infect Dis. 2011;203(3):306–311. doi:10.1093/jinfdis/jiq061.
   PubMed Web of Science ®Google Scholar
• Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10(8):575–582. doi:10.1038/nrmicro2819.
   PubMed Web of Science ®Google Scholar
• Icaza-Chávez ME. Gut microbiota in health and disease. Rev Gastroenterol Mex. 2013;78(4):240–248. doi:10.1016/j.rgmxen.2014.02.009.
   PubMedGoogle Scholar
• Flemer B, Lynch DB, Brown JM, Jeffery IB, Ryan FJ, Claesson MJ, O’Riordain M, Shanahan F, O’Toole PW. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut. 2017;66(4):633–643. doi:10.1136/gutjnl-2015-309595.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Matsumoto S. Gut microbiota and colorectal cancer. Genes and Environ. 2016;38(1):11. doi:10.1186/s41021-016-0038-8.
   PubMedGoogle Scholar
• Sun J, Kato I. Gut microbiota, inflammation and colorectal cancer. Genes Dis. 2016;3(2):130–143. doi:10.1016/j.gendis.2016.03.004.
   PubMed Web of Science ®Google Scholar
• Yachida S, Mizutani S, Shiroma H, Shiba S, Nakajima T, Sakamoto T, Watanabe H, Masuda K, Nishimoto Y, Kubo M. et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat Med. 2019;25(6):968–976. doi:10.1038/s41591-019-0458-7.
   PubMed Web of Science ®Google Scholar
• Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12(10):661–672. doi:10.1038/nrmicro3344.
   PubMed Web of Science ®Google Scholar
• Krautkramer KA, Fan J, Bäckhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19(2):77–94. doi:10.1038/s41579-020-0438-4.
   PubMed Web of Science ®Google Scholar
• Encarnação JC, Abrantes AM, Pires AS, Botelho MF. Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment. Cancer Metastasis Rev. 2015;34(3):465–478. doi:10.1007/s10555-015-9578-9.
   PubMed Web of Science ®Google Scholar
• He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR. et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity. Cell Metab. 2021;33(5):988–1000.e7. doi:10.1016/j.cmet.2021.03.002.
   PubMed Web of Science ®Google Scholar
• Fang Y, Yan C, Zhao Q, Xu J, Liu Z, Gao J, Zhu H, Dai Z, Wang D, Tang D. et al. The roles of microbial products in the development of colorectal cancer: a review. Bioengineered. 2021;12(1):720–735. doi:10.1080/21655979.2021.1889109.
   PubMed Web of Science ®Google Scholar
• Bernstein H, Bernstein C, Payne CM, Dvorak K. Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol. 2009;15(27):3329–3340. doi:10.3748/wjg.15.3329.
   PubMed Web of Science ®Google Scholar
• Fan X, Jin Y, Chen G, Ma X, Zhang L. Gut microbiota dysbiosis drives the development of colorectal cancer. Digestion. 2021;102(4):508–515. doi:10.1159/000508328.
   PubMed Web of Science ®Google Scholar
• Xu R, Wang Q, Li L. A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. BMC Genomics. 2015;16(Suppl 7):S4. doi:10.1186/1471-2164-16-S7-S4.
   PubMedGoogle Scholar
• Casero RA Jr, Murray Stewart T, Pegg AE. Polyamine metabolism and cancer: treatments, challenges and opportunities. Nat Rev Cancer. 2018;18(11):681–695. doi:10.1038/s41568-018-0050-3.
   PubMed Web of Science ®Google Scholar
• Johnson CH, Dejea CM, Edler D, Hoang LT, Santidrian AF, Felding BH, Ivanisevic J, Cho K, Wick E, Hechenbleikner E. et al. Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab. 2015;21(6):891–897. doi:10.1016/j.cmet.2015.04.011.
   PubMed Web of Science ®Google Scholar
• Lee YS, Kim TY, Kim Y, Lee SH, Kim S, Kang SW, Yang J-Y, Baek I-J, Sung YH, Park Y-Y. et al. Microbiota-derived lactate accelerates intestinal stem-cell-mediated epithelial development. Cell Host Microbe. 2018;24(6):833–846.e6. doi:10.1016/j.chom.2018.11.002.
   PubMed Web of Science ®Google Scholar
• Li R, Li Y, Kristiansen K, Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics. 2008;24(5):713–714. doi:10.1093/bioinformatics/btn025.
   PubMed Web of Science ®Google Scholar
• Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C, Salzberg SL. Versatile and open software for comparing large genomes. Genome Biol. 2004;5(2):R12. doi:10.1186/gb-2004-5-2-r12.
   PubMed Web of Science ®Google Scholar
• Zhang S, Xin F, Zhang X. The compound packaged in virions is the key to trigger host glycolysis machinery for virus life cycle in the cytoplasm. iScience. 2020;24(1):101915. doi:10.1016/j.isci.2020.101915.
   PubMed Web of Science ®Google Scholar
• Peng K, Kou L, Yu L, Bai C, Li M, Mo P, Li W, Yu C. Histone demethylase JMJD2D interacts with β-catenin to induce transcription and activate colorectal cancer cell proliferation and tumor growth in mice. Gastroenterology. 2019;156(4):1112–1126. doi:10.1053/j.gastro.2018.11.036.
   PubMed Web of Science ®Google Scholar
• Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, He W. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther. 2020;5(1):228. doi:10.1038/s41392-020-00313-5.
   PubMed Web of Science ®Google Scholar
• Grinat J, Heuberger J, Vidal RO, Goveas N, Kosel F, Berenguer-Llergo A, Kranz A, Wulf-Goldenberg A, Behrens D, Melcher B. et al. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness. Nat Commun. 2020;11(1):6422. doi:10.1038/s41467-020-20222-z.
   PubMed Web of Science ®Google Scholar
• Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, Moriyama E, Copeland J, Surendra A, Kumar S. et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell. 2014;158(2):288–299. doi:10.1016/j.cell.2014.04.051.
   PubMed Web of Science ®Google Scholar
• Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB. et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338(6103):120–123. doi:10.1126/science.1224820.
   PubMed Web of Science ®Google Scholar
• Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol. 2011;11(1):9–20. doi:10.1038/nri2891.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Gan Y, Zou R, Sha H, Lu Y, Zhang Y, Feng J. RNF128 suppresses the malignancy of colorectal cancer cells via inhibition of Wnt/β-catenin signaling. Am J Transl Res. 2021;13:13567–13578.
   PubMed Web of Science ®Google Scholar
• Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut. 2020;69(10):1867–1876. doi:10.1136/gutjnl-2020-321153.
   PubMed Web of Science ®Google Scholar
• Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16(11):690–704. doi:10.1038/s41575-019-0209-8.
   PubMed Web of Science ®Google Scholar
• Wong SH, Zhao L, Zhang X, Nakatsu G, Han J, Xu W, Xiao X, Kwong TNY, Tsoi H, Wu WKK. et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology. 2017;153(6):1621–1633.e6. doi:10.1053/j.gastro.2017.08.022.
   PubMed Web of Science ®Google Scholar
• Yu J, Feng Q, Wong SH, Zhang D, Liang QY, Qin Y, Tang L, Zhao H, Stenvang J, Li Y. et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2017;66(1):70–78. doi:10.1136/gutjnl-2015-309800.
   PubMed Web of Science ®Google Scholar
• Nakatsu G, Zhou H, Wu WKK, Wong SH, Coker OO, Dai Z, Li X, Szeto C-H, Sugimura N, Lam TYT. et al. Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology. 2018;155(2):529–541.e5. doi:10.1053/j.gastro.2018.04.018.
   PubMed Web of Science ®Google Scholar
• Meng C, Bai C, Brown TD, Hood LE, Tian Q. Human gut microbiota and gastrointestinal cancer. Genomics, Proteomics & Bioinformatics. 2018;16(1):33–49. doi:10.1016/j.gpb.2017.06.002.
   PubMed Web of Science ®Google Scholar
• Haenisch B, von Kügelgen I, Bönisch H, Göthert M, Sauerbruch T, Schepke M, Marklein G, Höfling K, Schröder D, Molderings GJ. et al. Regulatory mechanisms underlying agmatine homeostasis in humans. Am J Physiol Gastrointest Liver Physiol. 2008;295(5):G1104–10. doi:10.1152/ajpgi.90374.2008.
   PubMed Web of Science ®Google Scholar
• Shah SC, Itzkowitz SH. Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology. 2022;162(3):715–730.e3. doi:10.1053/j.gastro.2021.10.035.
   PubMed Web of Science ®Google Scholar
• Chatila WK, Walch H, Hechtman JF, Moyer SM, Sgambati V, Faleck DM, Srivastava A, Tang L, Benhamida J, Ismailgeci D. et al. Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nat Commun. 2023;14(1):110. doi:10.1038/s41467-022-35592-9.
   PubMed Web of Science ®Google Scholar
• Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J. et al. Agmatine: clinical applications after 100 years in translation. Drug Discov Today. 2013;18(17–18):880–893. doi:10.1016/j.drudis.2013.05.017.
   PubMed Web of Science ®Google Scholar
• Piletz JE, Klenotich S, Lee KS, Zhu QL, Valente E, Collins MA, Jones V, Lee SN, Yangzheng F. Putative agmatinase inhibitor for hypoxic-ischemic new born brain damage. Neurotox Res. 2013;24(2):176–190. doi:10.1007/s12640-013-9376-5.
   PubMed Web of Science ®Google Scholar